CBD CONDITIONS & TREATMENTS5 years ago
Tetra Bio-Pharma Inc.’s (OTCMKTS:TBPMF) Subsidiary Panag Pharma Completes Third Phase Study With Awaye
Tetra Bio-Pharma Inc.’s (OTCMKTS:TBPMF) subsidiary Panag Pharma Inc. has announced the completion of its Panag 001 third phase study evaluating the efficacy and safety of Topical-A...